newsfilter
← Latest News
FDA Approved Drugs·

Approval of ZOLPIMIST, NDA #022196 (Labeling)

Approval Date: 11/09/2026 Drug Name: ZOLPIMIST, NDA #022196 Submission: SUPPL-13 Active Ingredients: ZOLPIDEM TARTRATE Company: AYTU Submission Status: Approval Submission Classification: Labeling Application Number: 022196

Company
AYTU
Keywords
ZOLPIDEM TARTRATE